Detalles de la búsqueda
1.
Improvement of long-term risks of cardiovascular events associated with community-based disease management in Chinese patients of the Xinjiang autonomous region of China.
BMC Public Health
; 20(1): 1034, 2020 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32600440
2.
Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.
Stroke
; 46(10): 2830-7, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26316345
3.
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation.
Eur Heart J
; 35(28): 1897-906, 2014 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24513791
4.
Cost-effectiveness of targeted screening for non-valvular atrial fibrillation in the United Kingdom in older patients using digital approaches.
J Med Econ
; 26(1): 326-334, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36757910
5.
Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland.
J Med Econ
; 26(1): 963-972, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37527156
6.
Economic burden of antimicrobial resistance and inappropriate empiric treatment in Thailand.
Antimicrob Steward Healthc Epidemiol
; 3(1): e109, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37502249
7.
Cost-effectiveness of atrial fibrillation screening in Canadian community practice.
Heart Rhythm O2
; 4(2): 103-110, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36873310
8.
Modeling Challenges in Cost-Effectiveness Analysis of First-Line Immuno-Oncology Therapies in Non-small Cell Lung Cancer: A Systematic Literature Review.
Pharmacoeconomics
; 40(2): 183-201, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34595671
9.
Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain.
PLoS One
; 16(11): e0259251, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34767564
10.
Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy.
Clin Ther
; 42(5): 802-817, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32349879
11.
Economic evaluation of atorvastatin for prevention of recurrent stroke based on the SPARCL trial.
Value Health
; 12(6): 880-7, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19490555
12.
Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives.
Clinicoecon Outcomes Res
; 11: 659-672, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31807039
13.
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).
Antimicrob Resist Infect Control
; 8: 204, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31890160
14.
Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections.
Int J Antimicrob Agents
; 54(5): 633-641, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31202921
15.
Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria.
J Health Econ Outcomes Res
; 5(1): 39-54, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-37664691
16.
Stroke and systemic embolism prevention in patients with atrial fibrillation in Belgium: comparative cost effectiveness of new oral anticoagulants and warfarin.
Clin Drug Investig
; 35(2): 109-19, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25511639
17.
Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation.
Clin Ther
; 37(11): 2476-2488.e27, 2015 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26477648
18.
Process utility for imaging in cerebrovascular disease.
Acad Radiol
; 10(3): 266-74, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12643553
19.
Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation.
Thromb Res
; 134(2): 278-87, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24935675
20.
Cost effectiveness of apixaban versus aspirin for stroke prevention in patients with non-valvular atrial fibrillation in Belgium.
Clin Drug Investig
; 34(10): 709-21, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25164005